An Ottawa life sciences firm has the green light to test the product in the world’s most populous country as it looks to reverse years of sustained losses.
An Ottawa life sciences firm has the green light to test the product in the world’s most populous country as it looks to reverse years of sustained losses.
An Ottawa life sciences firm has the green light to test the product in the world’s most populous country as it looks to reverse years of sustained losses.
12.05.2022 - Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, . Seite 1